REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
07/07/2025
Back to search
Official data from USPTO
ONCOHOST A NEW DIMENSION TO CANCER CARE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
07/08/2025
Trademark type
Combined
Nice classes
5, 44
Filing date
09/19/2019
Registration date
07/07/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/07/2020
Last transaction
07/08/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
IL
Examiner
KUHN, RIO
Law office
N90
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized word "ONCOHOST" in blue letters with the letters "O" between the letters "C and "H" in a trapeze design outlined in blue with two circles in outlined in blue above the black wording "A NEW DIMENISION TO CANCER CARE". The color white represents background, outlining, shading, and/or transparent area and is not part of the mark
Holders and representatives
Holders
ONCOHOST LTD
Representatives
Roy D. Gross The Roy Gross Law Firm, LLC
Technical classification
Nice Classes
Class 5Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medicinal preparations for the treatment of cancer; diagnostic preparations for medical purposes; diagnostic kits comprising primarily diagnostic reagents for medical use in the field of oncology
Class 44
Medical analysis services for the prediction of response to cancer treatment and its associated clinical outcomes and for the identification of new drug targets for cancer treatment; medical testinganalyzing and reporting services for diagnostic or treatment purposes in the field of oncology
Publications
History of USPTO decisions and trademark events.
30 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
10/01/2022
FINV
FINAL DECISION TRANSACTION PROCESSED BY IB
11/14/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
10/29/2020
FIMP
FINAL DISPOSITION PROCESSED
10/29/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
10/07/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
07/07/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/21/2020
PUBO
PUBLISHED FOR OPPOSITION
04/21/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/01/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/16/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
03/16/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/16/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
03/16/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/16/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/01/2020
GNRT
NON-FINAL ACTION E-MAILED
03/01/2020
CNRT
NON-FINAL ACTION WRITTEN
03/01/2020
RFNT
REFUSAL PROCESSED BY IB
02/08/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/21/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/21/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/21/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/17/2020
RFRR
REFUSAL PROCESSED BY MPU
01/16/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/19/2019
CNRT
NON-FINAL ACTION WRITTEN
12/18/2019
DOCK
ASSIGNED TO EXAMINER
12/18/2019
MAFR
APPLICATION FILING RECEIPT MAILED
11/22/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/18/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/14/2019
Continuous trademark protection
Get notified about every new filing that threatens ONCOHOST A NEW DIMENSION TO CANCER CARE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.